tm logo
NEUMORA & DESIGN
FORMALIZED

on 24 Jan 2022

Last Applicant/ Owned by

NEUMORA THERAPEUTICS INC.

1700 Owens Str. #535San Francisco, CA 94158

US

Serial Number

2161753 filed on 24th Jan 2022

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

NEUMORA & DESIGN

Vienna Information


5 . 3 . 11

Other leavesAutres feuilles

5 . 3 . 13

Stylized leavesFeuilles stylisées

5 . 3 . 14

One leafUne feuille

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 15

Circles or ellipses containing representations of animals, parts of animals' bodies or plantsCercles ou ellipses contenant la représentation d'animaux, de parties du corps d'un animal ou de végétaux

26 . 1 . 12

Circles or ellipses containing one or more other geometrical figures -- Note: Including circles or ellipses containing bent or straight lines (except 26.1.10).Cercles ou ellipses contenant une ou plusieurs autres figures géométriques -- Note: Y compris les cercles ou ellipses contenant des lignes courbées ou droites (excepté 26.1.10).

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

Trademark usage description

a house mark for pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psych Read More

Classification Information


Class [005]
A house mark for pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders.


Classification kind code

11

Class [042]
Research and development of pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders; analyzing genetic, genomic, biological and clinical data for scientific research purposes; analyzing genetic, genomic, biological and clinical data for the research and development pharmaceuticals for treating neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders via targeted drug therapies.


Classification kind code

11

Mark Details


Serial Number

2161753

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 67
on 27th Sep 2024
Agent Name Changed
Submitted for opposition 287
on 14th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 24th Jan 2022
Filed
Submitted for opposition 1
on 24th Jan 2022
Created
Submitted for opposition 31
on 24th Jan 2022
Formalized